Jupiter Neurosciences, Inc. (NASDAQ:JUNS), a clinical-stage pharmaceutical company developing JOTROLâ„¢, a patented resveratrol-based therapeutic platform targeting neuroinflammation and mitochondrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback